Lupin receives final approval for Desoximetasone Cream
From USFDA
Lupin received final approval for its Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% from the United States Food and Drug Administration to market a generic equivalent of Taro Pharmaceuticals North America, Inc's Topicort LP Emollient Cream, 0.05% and Topicort Cream, 0.25%.The products are indicated for the relief of the inflammatory and pruritic manifestation of corticosteroid- responsive dermatoses.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 11 2017 | 3:16 PM IST